Combination chemotherapy following adrenal suppression in androgen- independent prostate cancer

European Urology

Volumn 38, Issue 3, 2000, Pages 255-258

  Sella, Avishay ^a   Flex, D ^a   Konichezky, M ^a   Sulkes, A ^a   Baniel, J ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Estramustine; Prostate cancer, hormone refractory; Vinblastine

Indexed keywords

AMINOGLUTETHIMIDE; DOXORUBICIN; ESTRAMUSTINE; ETOPOSIDE; HYDROCORTISONE; KETOCONAZOLE; MITOXANTRONE; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; VINBLASTINE;

ADRENAL SUPPRESSION; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; HORMONE RESISTANCE; HUMAN; MALE; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; PROSTATE CANCER; STOMATITIS;

EID: 0033844396     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020290     Document Type: Article

References (15)